http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103635463-B

Outgoing Links

Predicate Object
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01J2531-26
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01J20-3085
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01J31-1691
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01J20-226
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01J31-181
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D233-58
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D233-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B01J31-18
filingDate 2012-07-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2016-08-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2016-08-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-103635463-B
titleOfInvention Preparation comprises the method for the porous organo-metallic skeleton of Methylimidazole. zinc
abstract The method disclosing the porous metal-organic framework of a kind of organic compound prepared and comprise at least one at least two tooth with at least one metallic ion coordination, at least one of which metal ion is that the organic compound of zinc ion and at least one at least two tooth is based on 2 Methylimidazole .s, described method comprises the steps: that the first group water solution comprising zinc ion is added in the second group water solution comprising 2 Methylimidazole .s by (a), wherein forms suspension after adding the second solution;B the 3rd solution comprising highly basic is added in the suspension formed in step (a) by ().
priorityDate 2011-07-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-101432070-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-101443482-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010160661-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451326926
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID32051
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458437694
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457558965
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23994
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411738766
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419530971
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450116709
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21901440
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419566995
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425154543
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559351
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419531003
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24424
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12749
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414871446
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1390
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9257
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID406908050
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1639
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID68401
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453793281
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID67516
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID67195592
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8871
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411932836
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID887
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID20695

Total number of triples: 50.